Cancer - Stomach
Stomach cancer can develop in any part of the stomach and may spread throughout the stomach and to other organs; particularly the esophagus and the small intestine. Stomach cancer represents roughly 2% (25,500) cases of all new cancer cases yearly in the United States, but it is much more common in Japan, Great Britain, South America, and Iceland. It is associated with high salt in the diet, smoking, and low intake of fruits and vegetables. Infection with H. pylori is the main risk factor in about 80% or more of gastric cancers. It is more common in men.
A very small percentage of diffuse-type gastric cancers are thought to be genetic. Hereditary Diffuse Gastric Cancer (HDGC) has only recently been identified and research is ongoing, but genetic testing and treatment options are available for families at risk.
Metastasis occurs in 80-90% of individuals with stomach cancer, with a five year survival rate of 75% in those diagnosed in early stages and less than 30% of those diagnosed in late stages. The death rate is 12,400 a year in the United States.
Like any cancer, treatment is adapted to fit each person's individual needs and depends on the size, location, and extent of the tumor, the stage of the disease, and general health. Cancer of the stomach is difficult to cure unless it is found in an early stage (before it has begun to spread). Unfortunately, because early stomach cancer causes few symptoms, the disease is usually advanced when the diagnosis is made. Treatment for stomach cancer may include surgery, chemotherapy, and/or radiation therapy. New treatment approaches such as biological therapy and improved ways of using current methods are being studied in clinical trials.
...More at Wikipedia
Related Links:
Cancer - Stomach
Questions recently asked by other users
Latest Cancer / Oncology News From Medical News Today.
- Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
- Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
- GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
- Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
- Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
- Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
- Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
- Lymphoma Association Launches New Short Film
- New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
- Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
- Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
